AstraZeneca has struck a deal to acquire biotechnology company EsoBiotec for up to $1bn, as the London-listed pharmaceutical ...
The FTSE 100 company, which has a market capitalisation of £185.9 billion, confirmed the deal in an announcement to the London Stock Exchange on Monday. AstraZeneca was advised by a Covington team led ...
Don't miss AstraZeneca's CEO Pascal Soriot interview live on CNBC International at 11:30 a.m. London time / 7:30 a.m. ET. This breaking news story is being updated.
AstraZeneca announced a USD1 billion acquisition. Elsewhere, there are two planned floats announced for the AIM market. Here is what you need to know at the London market open: The average price ...
GlobalData on MSN8d
AstraZeneca director says AI must be a “thought partner” in drug discoverysenior director in oncology data science at AstraZeneca. Speaking at the ELRIG Drug Discovery meeting in London on 11 ...
The Cambridge, England-based pharmaceutical company said it will invest USD2.5 billion in China's capital to establish its sixth global strategic R&D centre alongside other major research and ...
The drugmaker plans to build a research-and-development center in Beijing and strike deals with local biotechnology companies ...
AstraZeneca (AZN) said Friday it plans to invest $2.5 billion in a new research and development hub in China as the drugmaker tries to reignite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback